EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma

J Hepatol. 2022 Sep;77(3):879-880. doi: 10.1016/j.jhep.2022.03.008. Epub 2022 Mar 28.

Authors

Peng Lin¹, Hong Yang²

Affiliations

¹ Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
² Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Electronic address: yanghong@gxmu.edu.cn.

PMID: 35358615
DOI: 10.1016/j.jhep.2022.03.008

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor
Carcinoma, Hepatocellular* / pathology
Humans
Liver Neoplasms* / pathology
Prognosis

Substances

Biomarkers, Tumor